Ignite Creation Date:
2024-06-16 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06427694
Status:
RECRUITING
Last Update Posted:
2024-06-10
First Post:
2024-05-20
Brief Title:
Low-Dose IL-2 For The Reduction Of Vascular Inflammation In ACS -Clinical Outcomes Follow-up Study
Sponsor:
Cambridge University Hospitals NHS Foundation Trust
Organization:
Cambridge University Hospitals NHS Foundation Trust
Organization Data
Organization:
Cambridge University Hospitals NHS Foundation Trust
Class:
OTHER
Study ID:
IVORY-FINALE A096877
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Cambridge University Hospitals NHS Foundation Trust
Lead Sponsor Class:
OTHER
Responsible Party:
Joseph Cheriyan MBChB MA FRCP FESC FACC
Responsible Party Title:
Dr Joseph Cheriyan Consultant Clinical PharmacologistAffilitated Associate Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Cambridge University Hospitals NHS Foundation Trust
Old Name:
None
Old Organization:
None